Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day: Minimal residual disease status in multiple myeloma 1 year after autologous hematopoietic cell transplantation and lenalidomide maintenance are associated with long-term overall survival.”
Authors: Marcelo Pasquini, Paul Wallace, Brent Logan, Manmeet Kaur, Joseph Tario Jr, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy Geller, Sergio Giralt, Parameswaran Hari, Mary M. Horowitz, John Koreth, Amrita Krishnan, Heather Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan Vogl, and Theresa Hahn.
Source: Robert Orlowski/X